PDE3B Antibodies

Santa Cruz Biotechnology features a diverse variety of PDE3B monoclonal antibodies for investigating phosphodiesterase 3B in cellular signaling pathways. PDE3B monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphodiesterase 3B (PDE3B) plays an essential role in regulating intracellular levels of cyclic AMP and cyclic GMP, which are crucial for numerous physiological processes, including lipid metabolism and insulin signaling. Dysregulation of PDE3B has been linked to various metabolic disorders, highlighting its significance as a therapeutic target. Research focused on PDE3B can enhance understanding of metabolic disease mechanisms and support development of new treatments. Investigating PDE3B expression patterns helps reveal its distribution across different tissues and cell types. Studying PDE3B interactions with other molecules provides valuable insights into signaling cascades and regulatory networks. Examining PDE3B activity levels under various conditions helps identify factors that influence enzyme function. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific knowledge of PDE3B's role in health and disease.